Help Lines 954-785-1121
 


You are not logged in. Upgrade Here
 <<<Previous Mid Day Report     Next Mid Day Report >>> 
 <<<Previous After Market Report Next After Market Report >>> 
You are not logged in.
This means you CAN ONLY VIEW reports that were published prior to Sunday, January 28, 2024.
You MUST UPGRADE YOUR MEMBERSHIP if you want to see any current reports.

 MIDDAY BREAKOUTS REPORT - TUESDAY, JULY 12TH, 2022
Previous Mid Day Report Next Mid Day Report >>>

DOW 31252.68 78.84 (0.25%) | NASDAQ 11360.79 -11.81 (-0.10%) | S&P 500 3853.57 -0.86 (-0.02%)
Time of Screening : 7/12/2022 12:13:12 PM         Report Released : 7/12/2022 12:36:01 PM
Price is: Above 52W High and Less Than 52W High but within 15% of the 52 Week High
Volume Is: At least 45% of 50 Day Average at the time of the screening.
More details about this report...

To View Current Notes and Data on currently Featured Stocks go to the latest
Featured Stocks Page
Symbol/Exchange
Company Name
Industry Group
PRICE CHANGE
(%Change)
Day High Volume
(% DAV)
(50 DAV)
52 Wk Hi
% From Hi
Date
Featured
Price
Featured
Pivot Point
Max Buy
CI - NYSE
Cigna Corp
$280.61 +0.70
0.25%
$282.33 1,451,699
77.22% of 50 DAV
50 DAV is 1,880,000
$281.49
-0.31%
7/7/2022 $276.55 PP = $273.68
MB = $287.36
Most Recent Note - 7/12/2022 12:20:08 PM
Y - Perched at its all-time high with today's 5th consecutive gain. Prior highs in the $273 area define initial support to watch on pullbacks. Volume-driven gains recently triggered a technical buy signal after a rebound above its 50 DMA line ($261) helped its outlook to improve.
>>> The latest Featured Stock Update with an annotated graph appeared on 7/7/2022. Click here.
View all notes | Alert me of new notes | Company Profile | SEC | News | ChartC A N S L I M

Symbol - Exchange - Industry Group
Company Name
Last Chg Day
High
52 WK Hi % From Hi Volume
% DAV
DAV
AMN - NYSE - Comml Svcs-Staffing
A M N Healthcare Svcs
$110.35 -6.66
-5.69%
$119.40 $129.12 -14.54% 342,178
47.52%
720,000
Most Recent Note for AMN - 7/12/2022 12:16:41 PM
Reversed into the red today after early gains approaching its 52-week high. Recently rebounded above its 50 and 200 DMA lines. Reported Mar '22 quarterly earnings +105% on +75% sales revenues versus the year ago period, its 5th strong quarter versus the year ago period. Annual earnings (A criteria) growth had a downturn on FY '19.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
ELA - AMEX - Retail/Whlsle-Jewelry
Envela Corporation
$7.47 -0.16
-2.10%
$7.74 $7.35 1.63% 151,564
189.46%
80,000
Most Recent Note for ELA - 7/12/2022 12:27:07 PM
Perched at its all time high today after a volume-driven gain on the prior session. Reported strong Mar '22 quarterly results versus the year ago period. Prior sales revenues and earnings history has not been a great match with the fact-based investment system's fundamental guidelines.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
GIB - NYSE - Computer - Tech Services
CGI Inc Cl A
$81.22 +0.99
1.23%
$81.83 $93.93 -13.53% 116,438
71.43%
163,000
Most Recent Note for GIB - 7/12/2022 12:29:52 PM
Reported earnings +7% on +6% sales revenues for the Mar '22 quarter versus the year ago period. Fundamental concerns remain. Sub par sales revenues and earnings growth leaves concerns with respect to the winning models of the fact-based investment system.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
RBA - NYSE - DIVERSIFIED SERVICES - Business/Management Services
Ritchie Bros Auctioneers
$66.33 +0.79
1.21%
$66.67 $76.18 -12.93% 244,872
50.08%
489,000
Most Recent Note for RBA - 7/12/2022 12:31:21 PM
Rebounded toward its 52-week high with a recently noted streak of volume-driven gains. Prior mid-day reports cautioned members - "Reported earnings +540% on +19% sales revenues for the Mar '22 quarter versus the year ago period. Prior quarterly and annual earnings (C and A criteria) history is not a match with the fact-based investment system's fundamental guidelines."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
SNEX - NASDAQ - Finance-Invest Bnk/Bkrs
StoneX Group Inc
$79.64 +2.67
3.47%
$81.05 $81.05 -1.74% 44,881
63.21%
71,000
Most Recent Note for SNEX - 7/12/2022 12:33:16 PM
Matched its all-time high with today's gain adding to recent gains lacking great volume while consolidating above its 50 DMA line. Found support recently at its 200 DMA line. Noted in prior mid-day reports - "Reported Mar '22 quarterly earnings +16% on +46% sales revenues versus the year ago period. It has earned high Earnings Per Share and Relative Strength ranks, however, its quarterly and annual earnings history (C and A criteria) is not a great match with the fact-based investment system's fundamental guidelines.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
TAP - NYSE - Beverages-Alcoholic
Molson Coors Brewing B
$57.91 +1.85
3.30%
$58.42 $57.75 0.28% 947,914
60.57%
1,565,000
Most Recent Note for TAP - 7/12/2022 12:34:34 PM
Today's 3rd consecutive gain has it rallying above recent highs and toward its 52-week high. Reported strong Dec '21 and Mar '22 quarterly results versus the year ago periods. Prior quarterly and annual earnings history (C and A criteria) has been lackluster and is not a match with the fundamental guidelines of the fact-based investment system.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
USAK - NASDAQ - TRANSPORTATION - Trucking
U S A Truck Inc
$31.13 +0.04
0.13%
$31.32 $31.67 -1.71% 182,425
66.82%
273,000
Most Recent Note for USAK - 7/12/2022 12:35:05 PM
Holding its ground after a gap up on 6/24/22 M&A news. Recent quarterly comparisons through Mar '22 were strong but its prior earnings history is not a match with the fundamental guidelines of the fact-based investment system.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
VIVO - NASDAQ - DRUGS - Diagnostic Substances
Meridian Bioscience Inc
$33.00 +0.02
0.06%
$33.05 $34.38 -4.01% 820,011
119.88%
684,000
Most Recent Note for VIVO - 7/12/2022 12:35:55 PM
Perched near its 52-week high following volume-driven gains after M&A news this week. Prior mid-day reports cautioned members - "Quarterly earnings increases through Mar '22 versus the year ago periods have been below the +25% minimum guideline (C criteria). Up and down annual earnings (A criteria) history is not a match with the fact-based investment system's fundamental guidelines. On 4/18/08 it was dropped from the Featured Stocks list."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  

THESE ARE NOT BUY RECOMMENDATIONS!  Comments contained in the body of this report are technical opinions only. The material herein has been obtained from sources believed to be reliable and accurate, however, its accuracy and completeness cannot be guaranteed. We are not an investment advisor, hence it does not endorse or recommend any securities or other investments. Any recommendation contained in this report may not be suitable for all investors and it is not to be deemed an offer or solicitation on our part with respect to the purchase or sale of any securities. All trademarks, service marks and trade names appearing in this report are the property of their respective owners, and are likewise used for identification purposes only.

This report is a service available only to active Paid Premium Members. You may opt-out of receiving report notifications at any time.  Questions or comments may be submitted by writing to FactBasedInvesting.com c/o Premium Member Services 665 S.E. 10 Street, Suite 201 Deerfield Beach, FL 33441-5634 or by calling 954-785-1121.

 We appreciate any feedback members may wish to send via the inquiry form here.

Kenneth J. Gruneisen founded Gruneisen Growth Corp. (2003), which prior to May 11, 2015, operated CANSLIM.net and CANSLIM.com both under license from Data Analysis Inc. / Investor's Business Daily. Kenneth has passed the CAN SLIM® Master's Exam. Gruneisen Growth Corp. now continues over two decades of fact based market analysis via FactBasedInvesting.com.

Copyright © 1996-2024 Gruneisen Growth Corp. All rights reserved. Protected by the copyright laws of the United States and Canada and by international treaties

Privacy Policy | Terms of Use | Contact Us